Onychomycosis Treatment Market - Global Outlook and Forecast 2023-2028

Report ID: 1370033 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Onychomycosis Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Onychomycosis Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Onychomycosis Treatment Overall Market Size
    2.1 Global Onychomycosis Treatment Market Size: 2021 VS 2028
    2.2 Global Onychomycosis Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Onychomycosis Treatment Players in Global Market
    3.2 Top Global Onychomycosis Treatment Companies Ranked by Revenue
    3.3 Global Onychomycosis Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Onychomycosis Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Onychomycosis Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Onychomycosis Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Onychomycosis Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Onychomycosis Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Onychomycosis Treatment Market Size Markets, 2021 & 2028
        4.1.2 Medication
        4.1.3 Lasers
        4.1.4 Photodynamic Therapy
    4.2 By Type - Global Onychomycosis Treatment Revenue & Forecasts
        4.2.1 By Type - Global Onychomycosis Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Onychomycosis Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Onychomycosis Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Onychomycosis Treatment Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Dermatology Clinics
        5.1.4 Retail Pharmacies
        5.1.5 Online Pharmacies
    5.2 By Application - Global Onychomycosis Treatment Revenue & Forecasts
        5.2.1 By Application - Global Onychomycosis Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Onychomycosis Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Onychomycosis Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Onychomycosis Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Onychomycosis Treatment Revenue & Forecasts
        6.2.1 By Region - Global Onychomycosis Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Onychomycosis Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Onychomycosis Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Onychomycosis Treatment Revenue, 2017-2028
        6.3.2 US Onychomycosis Treatment Market Size, 2017-2028
        6.3.3 Canada Onychomycosis Treatment Market Size, 2017-2028
        6.3.4 Mexico Onychomycosis Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Onychomycosis Treatment Revenue, 2017-2028
        6.4.2 Germany Onychomycosis Treatment Market Size, 2017-2028
        6.4.3 France Onychomycosis Treatment Market Size, 2017-2028
        6.4.4 U.K. Onychomycosis Treatment Market Size, 2017-2028
        6.4.5 Italy Onychomycosis Treatment Market Size, 2017-2028
        6.4.6 Russia Onychomycosis Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Onychomycosis Treatment Market Size, 2017-2028
        6.4.8 Benelux Onychomycosis Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Onychomycosis Treatment Revenue, 2017-2028
        6.5.2 China Onychomycosis Treatment Market Size, 2017-2028
        6.5.3 Japan Onychomycosis Treatment Market Size, 2017-2028
        6.5.4 South Korea Onychomycosis Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Onychomycosis Treatment Market Size, 2017-2028
        6.5.6 India Onychomycosis Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Onychomycosis Treatment Revenue, 2017-2028
        6.6.2 Brazil Onychomycosis Treatment Market Size, 2017-2028
        6.6.3 Argentina Onychomycosis Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Onychomycosis Treatment Revenue, 2017-2028
        6.7.2 Turkey Onychomycosis Treatment Market Size, 2017-2028
        6.7.3 Israel Onychomycosis Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Onychomycosis Treatment Market Size, 2017-2028
        6.7.5 UAE Onychomycosis Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Onychomycosis Treatment Major Product Offerings
        7.1.4 Pfizer Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.1.5 Pfizer Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Onychomycosis Treatment Major Product Offerings
        7.2.4 Novartis Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Corporate Summary
        7.3.2 Johnson & Johnson Business Overview
        7.3.3 Johnson & Johnson Onychomycosis Treatment Major Product Offerings
        7.3.4 Johnson & Johnson Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.3.5 Johnson & Johnson Key News
    7.4 Bausch Health
        7.4.1 Bausch Health Corporate Summary
        7.4.2 Bausch Health Business Overview
        7.4.3 Bausch Health Onychomycosis Treatment Major Product Offerings
        7.4.4 Bausch Health Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.4.5 Bausch Health Key News
    7.5 Bayer
        7.5.1 Bayer Corporate Summary
        7.5.2 Bayer Business Overview
        7.5.3 Bayer Onychomycosis Treatment Major Product Offerings
        7.5.4 Bayer Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.5.5 Bayer Key News
    7.6 Lumenis
        7.6.1 Lumenis Corporate Summary
        7.6.2 Lumenis Business Overview
        7.6.3 Lumenis Onychomycosis Treatment Major Product Offerings
        7.6.4 Lumenis Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.6.5 Lumenis Key News
    7.7 Galderma
        7.7.1 Galderma Corporate Summary
        7.7.2 Galderma Business Overview
        7.7.3 Galderma Onychomycosis Treatment Major Product Offerings
        7.7.4 Galderma Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.7.5 Galderma Key News
    7.8 Moberg Pharma
        7.8.1 Moberg Pharma Corporate Summary
        7.8.2 Moberg Pharma Business Overview
        7.8.3 Moberg Pharma Onychomycosis Treatment Major Product Offerings
        7.8.4 Moberg Pharma Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.8.5 Moberg Pharma Key News
    7.9 Cipla
        7.9.1 Cipla Corporate Summary
        7.9.2 Cipla Business Overview
        7.9.3 Cipla Onychomycosis Treatment Major Product Offerings
        7.9.4 Cipla Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.9.5 Cipla Key News
    7.10 Biofrontera
        7.10.1 Biofrontera Corporate Summary
        7.10.2 Biofrontera Business Overview
        7.10.3 Biofrontera Onychomycosis Treatment Major Product Offerings
        7.10.4 Biofrontera Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.10.5 Biofrontera Key News
    7.11 Leo Pharma
        7.11.1 Leo Pharma Corporate Summary
        7.11.2 Leo Pharma Business Overview
        7.11.3 Leo Pharma Onychomycosis Treatment Major Product Offerings
        7.11.4 Leo Pharma Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.11.5 Leo Pharma Key News
    7.12 Dr. Reddy's Laboratories
        7.12.1 Dr. Reddy's Laboratories Corporate Summary
        7.12.2 Dr. Reddy's Laboratories Business Overview
        7.12.3 Dr. Reddy's Laboratories Onychomycosis Treatment Major Product Offerings
        7.12.4 Dr. Reddy's Laboratories Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.12.5 Dr. Reddy's Laboratories Key News
    7.13 Medimetriks Pharmaceuticals
        7.13.1 Medimetriks Pharmaceuticals Corporate Summary
        7.13.2 Medimetriks Pharmaceuticals Business Overview
        7.13.3 Medimetriks Pharmaceuticals Onychomycosis Treatment Major Product Offerings
        7.13.4 Medimetriks Pharmaceuticals Onychomycosis Treatment Revenue in Global Market (2017-2022)
        7.13.5 Medimetriks Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Onychomycosis Treatment Market Opportunities & Trends in Global Market
    Table 2. Onychomycosis Treatment Market Drivers in Global Market
    Table 3. Onychomycosis Treatment Market Restraints in Global Market
    Table 4. Key Players of Onychomycosis Treatment in Global Market
    Table 5. Top Onychomycosis Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Onychomycosis Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Onychomycosis Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Onychomycosis Treatment Product Type
    Table 9. List of Global Tier 1 Onychomycosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Onychomycosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Onychomycosis Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Onychomycosis Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Onychomycosis Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Onychomycosis Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Onychomycosis Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Onychomycosis Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Onychomycosis Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Onychomycosis Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Onychomycosis Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Onychomycosis Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Onychomycosis Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Onychomycosis Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Onychomycosis Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Onychomycosis Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Onychomycosis Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Onychomycosis Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Onychomycosis Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Onychomycosis Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Onychomycosis Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Pfizer Corporate Summary
    Table 31. Pfizer Onychomycosis Treatment Product Offerings
    Table 32. Pfizer Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis Onychomycosis Treatment Product Offerings
    Table 35. Novartis Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Johnson & Johnson Corporate Summary
    Table 37. Johnson & Johnson Onychomycosis Treatment Product Offerings
    Table 38. Johnson & Johnson Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. Bausch Health Corporate Summary
    Table 40. Bausch Health Onychomycosis Treatment Product Offerings
    Table 41. Bausch Health Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Bayer Corporate Summary
    Table 43. Bayer Onychomycosis Treatment Product Offerings
    Table 44. Bayer Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Lumenis Corporate Summary
    Table 46. Lumenis Onychomycosis Treatment Product Offerings
    Table 47. Lumenis Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. Galderma Corporate Summary
    Table 49. Galderma Onychomycosis Treatment Product Offerings
    Table 50. Galderma Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Moberg Pharma Corporate Summary
    Table 52. Moberg Pharma Onychomycosis Treatment Product Offerings
    Table 53. Moberg Pharma Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Cipla Corporate Summary
    Table 55. Cipla Onychomycosis Treatment Product Offerings
    Table 56. Cipla Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
    Table 57. Biofrontera Corporate Summary
    Table 58. Biofrontera Onychomycosis Treatment Product Offerings
    Table 59. Biofrontera Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
    Table 60. Leo Pharma Corporate Summary
    Table 61. Leo Pharma Onychomycosis Treatment Product Offerings
    Table 62. Leo Pharma Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
    Table 63. Dr. Reddy's Laboratories Corporate Summary
    Table 64. Dr. Reddy's Laboratories Onychomycosis Treatment Product Offerings
    Table 65. Dr. Reddy's Laboratories Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
    Table 66. Medimetriks Pharmaceuticals Corporate Summary
    Table 67. Medimetriks Pharmaceuticals Onychomycosis Treatment Product Offerings
    Table 68. Medimetriks Pharmaceuticals Onychomycosis Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Onychomycosis Treatment Segment by Type in 2021
    Figure 2. Onychomycosis Treatment Segment by Application in 2021
    Figure 3. Global Onychomycosis Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Onychomycosis Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Onychomycosis Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Onychomycosis Treatment Revenue in 2021
    Figure 8. By Type - Global Onychomycosis Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Onychomycosis Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Onychomycosis Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Onychomycosis Treatment Revenue Market Share, 2017-2028
    Figure 12. US Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Onychomycosis Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Onychomycosis Treatment Revenue Market Share, 2017-2028
    Figure 24. China Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Onychomycosis Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Onychomycosis Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Onychomycosis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Pfizer Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Johnson & Johnson Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Bausch Health Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Bayer Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Lumenis Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Galderma Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Moberg Pharma Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Cipla Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Biofrontera Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Leo Pharma Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Dr. Reddy's Laboratories Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Medimetriks Pharmaceuticals Onychomycosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
Onychomycosis Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Onychomycosis Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Onychomycosis Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports